Health Effects of Cetoleic Acid (A Randomized Double Blinded Controlled Trial)
Launched by UNIVERSITY OF OSLO · Apr 8, 2021
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This is a randomized double-blinded controlled trial ( randomized 1:1). Study population: healthy men and women 20-70 years, BMI 20-35 kg/m2.
Study design:
* 3 weeks run-in-period where all participants consume control capsules every morning.
* Randomization intervention: control (1:1). All participants consume their capsules (control or intervention) for 4 weeks.
The intervention oil consists of a fish oil high in cetoleic acid and the control oil is a mix of different oils and low in cetoleic acid.
Power calculation and sample size:
It was expected a difference of 15% in n-3 between ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • BMI 20-35kg/m2
- • opportunity to meet for 3 visits at the Department of Nutrition, University of Oslo, during the study period.
- Exclusion Criteria:
- • Chronic disease (liver/kidney/metabolism)
- • Alcohol overconsumption (\>40g/day)
- • Diabetes and high fasting blood glucose
- • Pregnant/ breastfeeding or planning pregnancy during the study period
- • High fish intake (\>3 meals/week).
- • Blood donation during the study period
- • Difficulty following the study protocol.
- • Smoking/snuffing
- • Regularly use of anti-inflammatory drugs
- • Regularly use of omega-3 supplements /cod liver oil.
About University Of Oslo
The University of Oslo, a leading research institution in Norway, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration and ethical research practices, the university harnesses its extensive expertise in various fields, including medicine, health sciences, and biomedical research. The University of Oslo actively engages in clinical trials aimed at exploring new therapies and interventions, fostering a culture of scientific inquiry, and contributing to the global understanding of health and disease. Through its commitment to excellence and rigorous methodologies, the university seeks to translate research findings into tangible benefits for patients and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, , Norway
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials